Decoy Therapeutics (DCOY) Change in Acquisitions & Divestments (2015 - 2018)

Decoy Therapeutics (DCOY) has reported Change in Acquisitions & Divestments for 4 consecutive years, with $2.0 million the latest figure, recorded in Q2 2018.

• In Q2 2018, Change in Acquisitions & Divestments fell 91.59% year-over-year to $2.0 million; the TTM figure through Mar 2019 stood at $2.0 million (down 96.38% YoY), while the FY2018 annual figure was $16.1 million, down 72.01% from the prior year.
• Change in Acquisitions & Divestments slipped to $2.0 million in Q2 2018 per DCOY's latest filing, from $14.1 million in the prior quarter.
• Across five years, Change in Acquisitions & Divestments topped out at $23.8 million in Q2 2017 and bottomed at $1.4 million in Q4 2015.
• Historically, Change in Acquisitions & Divestments has averaged $9.4 million across 4 years, with a median of $9.8 million in 2015.
• Annual changes were most pronounced in 2016 — Change in Acquisitions & Divestments jumped 723.25% — and 2018, when it slumped 91.59%.
• Decoy Therapeutics' Change in Acquisitions & Divestments stood at $1.4 million in 2015, then surged by 723.25% to $11.5 million in 2016, then climbed by 24.07% to $14.3 million in 2017, then tumbled by 86.01% to $2.0 million in 2018.
• Business Quant data shows DCOY's Change in Acquisitions & Divestments at $2.0 million in Q2 2018, $14.1 million in Q1 2018, and $14.3 million in Q4 2017.